Situation normale

XLENCE PHARMA
 SRL

1421 Braine-l'Alleud
Since 19/10/2022
BE0792642824
Financial Health Indicator
6
Equity
€37.8K
Gross Operating Margin
€53.7K
EBITDA
€52.8K
Gain/Loss
€32.8K

XLENCE PHARMA’s business network visualized

Explore our interactive spiderweb to visually navigate XLENCE PHARMA’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb XLENCE PHARMA
XLENCE PHARMA
  • Morgane VAN DE STADT
    1421 Ophain-Bois-Seigneur-Isaac

Detailed insights into XLENCE PHARMA’s financial history

See financial trends including, equity, operating income, profit/loss and employees of XLENCE PHARMA. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023
Equity
37.8K
Gross Operating Margin
53.7K
Gain/Loss
32.8K

Find similar companies like XLENCE PHARMA

Find more companies with similar activities to XLENCE PHARMA from our extensive database.

Frequently asked questions about XLENCE PHARMA

  • Where is XLENCE PHARMA located?

    XLENCE PHARMA’s headquarters is located in Rue du Try 43 , 1421 Braine-l'Alleud.

  • Who are the directors of XLENCE PHARMA?

    XLENCE PHARMA’s directors include
    • Morgane VAN DE STADT

  • When was XLENCE PHARMA founded?

    XLENCE PHARMA was founded in 2022-10-19. XLENCE PHARMA has been active for 2 years.

  • What are XLENCE PHARMA’s NACEBEL codes?

    XLENCE PHARMA’s NACEBEL codes are
    • 70220 Conseil pour les affaires et autres conseils de gestion (2008)

  • What is XLENCE PHARMA’s VAT number?

    XLENCE PHARMA’s VAT number is BE0792642824.

  • What is XLENCE PHARMA’s juridical form?

    XLENCE PHARMA’s juridical type is Société à responsabilité limitée (SRL).

  • How is the financial situation of XLENCE PHARMA?

    openthebox has estimated that XLENCE PHARMA’s financial health score to be 6/10.